Patents – the Starting Gun in the Race for the Human Genome

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Bradley, Patrick	en_US
dc.date.accessioned	2012-12-07T15:16:04Z
dc.date.issued	2005	en_US
dc.identifier.citation	Patents – the Starting Gun in the Race for the Human Genome (2005 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:10015275
dc.description.abstract	The race to sequence the human genome between the federal government’s Human Genome Project and the private firm Celera Genomics is one of the most fascinating tales in the history of science. This paper explores the role that the prospect of obtaining patents on these DNA sequences played in stimulating that race. It then examines different policy rationales for and against DNA sequence patents. In doing so, two competing goals rise to the surface – incentivizing the creation of downstream products versus maintaining an open and cordial research environment. Finally, the paper explores how the current law deals with these objectives and suggests a number of possible changes to strike a better balance.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	genome	en
dc.subject	patent	en
dc.title	Patents – the Starting Gun in the Race for the Human Genome	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-12-07T15:16:04Z